GETECCU, o. b. o. t. E. s. g. o. (2019). Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: Study protocol of a prospective, multicentre, randomized clinical trial.
Chicago Style CitationGETECCU, on behalf of the EXIT study group of. Anti-tumour Necrosis Factor Discontinuation in Inflammatory Bowel Disease Patients in Remission: Study Protocol of a Prospective, Multicentre, Randomized Clinical Trial. 2019.
MLA CitationGETECCU, on behalf of the EXIT study group of. Anti-tumour Necrosis Factor Discontinuation in Inflammatory Bowel Disease Patients in Remission: Study Protocol of a Prospective, Multicentre, Randomized Clinical Trial. 2019.
Warning: These citations may not always be 100% accurate.